zhao xuejin

Dr. zhao xuejin


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 May 2022 in Life
Verified
Journal Article
Open access
PDF file
ZXzhao xuejin
zhao xuejin
YZYeqing Zong
Yeqing Zong
WWWeijia Wei
Weijia Wei
Chunbo LouChunbo Lou
Chunbo Lou
Thaxtomin A is a potent bioherbicide in both organic and conventional agriculture; however, its low yield hinders its wide application. Here, we report the direct cloning and heterologous expression of the thaxtomin A gene cluster in three well-characterized Streptomyces hosts. Then, we present an efficient, markerless and multiplex large gene cluster editing method based on in vitro CRISPR/Cas9 digestion and yeast homologous recombination. With this method, we successfully engineered the thaxtomin A cluster by simultaneously replacing the native promoters of the txtED operon, txtABH operon and txtC gene with strong constitutive promoters, and the yield of thaxtomin A improved to 289.5 µg/mL in heterologous Streptomyces coelicolor M1154. To further optimize the biosynthetic pathway, we used constraint-based combinatorial design to build 27 refactored gene clusters by varying the promoter strength of every operon, and the highest titer of thaxtomin A production reached 504.6 μg/mL. Taken altogether, this work puts forward a multiplexed promoter engineering strategy to engineer secondary metabolism gene clusters for efficiently improving fermentation titers.

17 November 2021 in Life
Verified
Journal Article
Open access
PDF file
PDPei Du
Pei Du
Chunbo LouChunbo Lou
Chunbo Lou
ZXzhao xuejin
zhao xuejin
QWQihui Wang
Qihui Wang
XJXiangyu Ji
Xiangyu Ji
WWWeijia Wei
Weijia Wei
CRISPR-based enzymes have offered a unique capability to the design of genetic switches, with advantages in designability, modularity and orthogonality. CRISPR-based genetic switches operate on multiple levels of life, including transcription and translation. In both prokaryotic and eukaryotic cells, deactivated CRISPR endonuclease and endoribonuclease have served in genetic switches for activating or repressing gene expression, at both transcriptional and translational levels. With these genetic switches, more complex circuits have been assembled to achieve sophisticated functions including inducible switches, non-linear response and logical biocomputation. As more CRISPR enzymes continue to be excavated, CRISPR-based genetic switches will be used in a much wider range of applications.

2 November 2024 in Microbial Biotechnology
Verified
Journal Article
Open access
XLXingwang Li
Xingwang Li
ZSZiwei Sang
Ziwei Sang
ZXzhao xuejin
zhao xuejin
6227000011170942189 Wen6227000011170942189 Wen
6227000011170942189 Wen
Daptomycin (DAP), a novel cyclic lipopeptide antibiotic produced by Streptomyces roseosporus , is clinically important for treatment of infections caused by multidrug‐resistant Gram‐positive pathogens, but the low yield hampers its large‐scale industrial production. Here, we describe a combination metabolic engineering strategy for constructing a DAP high‐yielding strain. Initially, we enhanced aspartate (Asp) precursor supply in S. roseosporus wild‐type (WT) strain by separately inhibiting Asp degradation and competitive pathway genes using CRISPRi and overexpressing Asp synthetic pathway genes using strong promoter kasOp* . The resulting strains all showed increased DAP titre. Combined inhibition of acsA4 , pta , pyrB , and pyrC increased DAP titre to 167.4 μg/mL (73.5% higher than WT value). Co‐overexpression of aspC , gdhA , ppc , and ecaA led to DAP titre 168 μg/mL (75.7% higher than WT value). Concurrently, we constructed a chassis strain favourable for DAP production by abolishing by‐product production (i.e., deleting a 21.1 kb region of the red pigment biosynthetic gene cluster (BGC)) and engineering the DAP BGC (i.e., replacing its native dptEp with kasOp* ). Titre for the resulting chassis strain reached 185.8 μg/mL. Application of our Asp precursor supply strategies to the chassis strain further increased DAP titre to 302 μg/mL (2.1‐fold higher than WT value). Subsequently, we cloned the engineered DAP BGC and duplicated it in the chassis strain, leading to DAP titre 274.6 μg/mL. The above strategies, in combination, resulted in maximal DAP titre 350.7 μg/mL (2.6‐fold higher than WT value), representing the highest reported DAP titre in shake‐flask fermentation. These findings provide an efficient combination strategy for increasing DAP production and can also be readily applied in the overproduction of other Asp‐related antibiotics.

1 March 2024 in Synthetic and Systems Biotechnology
Verified
Journal Article
Open access
ZXzhao xuejin
zhao xuejin
YZYeqing Zong
Yeqing Zong
QLQiuli Lou
Qiuli Lou
CQChenrui Qin
Chenrui Qin
Chunbo LouChunbo Lou
Chunbo Lou
Streptomyces has enormous potential to produce novel natural products (NPs) as it harbors a huge reservoir of uncharacterized and silent natural product biosynthetic gene clusters (BGCs). However, the lack of efficient gene cluster engineering strategies has hampered the pace of new drug discovery. Here, we developed an easy-to-use, highly flexible DNA assembly toolkit for gene cluster engineering. The DNA assembly toolkit is compatible with various DNA assembling approaches including Biobrick, Golden Gate, CATCH, yeast homologous recombination-based DNA assembly and homing endonuclease-mediated assembly. This compatibility offers great flexibility in handling multiple genetic parts or refactoring large gene clusters. To demonstrate the utility of this toolkit, we quantified a library of modular regulatory parts, and engineered a gene cluster (act) using characterized promoters that led to increased production. Overall, this work provides a powerful part assembly toolkit that can be used for natural product discovery and optimization in Streptomyces.

31 December 2024 in Microbial Cell Factories
Verified
Journal Article
Open access
PDF file
DXDongmei Xu
Dongmei Xu
YWYaoyao Wang
Yaoyao Wang
HLHongzhen Li
Hongzhen Li
BWBing Wang
Bing Wang
LCLibin Chai
Libin Chai
XZXuexia Zhang
Xuexia Zhang
Rapamycin is an important natural macrolide antibiotic with antifungal, immunosuppressive and antitumor activities produced by Streptomyces rapamycinicus. However, their prospective applications are limited by low fermentation units. In this study, we found that the exogenous aromatic amino acids phenylalanine and tyrosine could effectively increase the yield of rapamycin in industrial microbial fermentation. To gain insight into the mechanism of rapamycin overproduction, comparative transcriptomic profiling was performed between media with and without phenylalanine and tyrosine addition. The results showed that the addition of phenylalanine and tyrosine upregulated the transcription levels of genes involved in rapamycin biosynthesis, precursor production, and transporters. In addition, the transcription levels of many carbohydrate metabolism-related genes were down-regulated, leading to a decrease in growth, suggesting that balancing cell growth and rapamycin biosynthesis may be important to promote efficient biosynthesis of rapamycin in Streptomyces rapamycinicus. These results provide a basis for understanding physiological roles of phenylalanine and tyrosine, and a new way to increase rapamycin production in Streptomyces cultures.